#18: TheMachine: ADXS Stock News : Advaxis Applies for $2.0 Million U.S. Bio-Defense Grant
Responds To Solicitation from Northeast Biodefense Center to
Develop... |
June 1, 2009
12:35:01 AM |
#17: TheMachine: ADXS Stock News : Advaxis Receives US Patent and Trademark Office Approval on Act-A Protein Patent-Pending Rights
Compositions and Methods for Enhancing Immunogenicity of Antigens
... |
May 30, 2009
11:11:44 PM |
#16: Stock News Bot: ADXS News Two Leading Biotech Publications Report on Advaxis' Listeria Platform Technology
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (OTCBB: ADXS), a... |
March 15, 2007
06:06:00 AM |
#15: Stock News Bot: ADXS News Advaxis Partners with Gynecologic Oncology Group for Phase II Study of Company's Lead Cervical Cancer Vaccine
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (OTCBB: ADXS) has received... |
December 19, 2006
06:58:00 AM |
#14: Stock News Bot: ADXS News Advaxis Names Thomas A. Moore to Serve as CEO and Chairman of the Board
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (OTCBB: ADXS) a... |
December 18, 2006
05:30:00 AM |
#13: Stock News Bot: ADXS News Advaxis Completes Dosing and Enrollment of First Cohort of Patients in Phase I/II Cervical Cancer Vaccine Trial
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (OTCBB: ADXS)
has... |
November 7, 2006
04:00:00 AM |
#12: Stock News Bot: ADXS News Advaxis to Present at Rodman & Renshaw 8th Annual Healthcare Conference on November 8, 2006
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (OTCBB: ADXS) will... |
October 30, 2006
05:30:00 AM |
#11: Stock News Bot: ADXS News Advaxis Meets with FDA Regarding Phase II of Lovaxin C
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (OTCBB: ADXS) has conducted... |
September 25, 2006
05:30:00 AM |
#10: Stock News Bot: ADXS News Advaxis Appoints Thomas A. Moore to Its Board of Directors; Todd Derbin Resigns as Chairman of the Board
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Sept. 11, 2006--Advaxis (OTCBB: ADXS) has... |
September 11, 2006
05:30:00 AM |
#9: Stock News Bot: ADXS News Two Leading Biotech Publications Report on Advaxis' Potential Treatment for Cervical Cancer
PRINCETON, N.J.--(BUSINESS WIRE)--Dec. 12, 2005--Two leading biotech publications... |
December 12, 2005
03:03:00 AM |
#8: Stock News Bot: ADXS News Advaxis, Inc. and Cobra Biomanufacturing Plc Enter a Strategic Collaboration and Long-Term Vaccine Supply Agreement for Listeria Cancer Vaccines
PRINCETON N.J.--(BUSINESS WIRE)--Nov. 7, 2005--Advaxis, Inc. (OTCBB: ADXS), a... |
November 7, 2005
01:00:00 AM |
#7: Stock News Bot: ADXS News Advaxis to Present at the Rodman and Renshaw Techvest 7th Annual Healthcare Conference
PRINCETON, N.J.--(BUSINESS WIRE)--Nov. 3, 2005--Advaxis, Inc. (OTCBB: ADXS), a... |
November 3, 2005
10:27:00 AM |
#6: Stock News Bot: ADXS News Advaxis' Vaccine Candidate to Treat Existing Cervical Cancer
PRINCETON, N.J.--(BUSINESS WIRE)--Oct. 10, 2005--Advaxis (OTCBB: ADXS), today... |
October 10, 2005
01:00:00 AM |
#5: Stock News Bot: ADXS News Advaxis' Listeria Cancer Vaccine Results in Complete Regression of Rapidly Growing Breast Tumors
PRINCETON, N.J.--(BUSINESS WIRE)--Sept. 26, 2005--Advaxis, Inc. (OTCBB: ADXS)... |
September 26, 2005
12:00:00 AM |
#4: Stock News Bot: ADXS News Advaxis' Listeria Cancer Vaccine Shows Strong Safety Profile In Toxicology Studies
PRINCETON, N.J.--(BUSINESS WIRE)--Aug. 29, 2005--Advaxis, Inc. (OTCBB: ADXS)... |
August 29, 2005
02:00:00 AM |
